Status:
COMPLETED
MELT - MRI Evaluation of Lymphoma Treatment
Lead Sponsor:
University College, London
Conditions:
Lymphoma, Hodgkin
Eligibility:
All Genders
5-20 years
Brief Summary
Patients who are newly diagnosed with Hodgkin's lymphoma will undergo disease staging at diagnosis and initial treatment response assessment. At each time point (initial staging and treatment response...
Detailed Description
The trial will be a single centre cohort study in patients newly diagnosed with Hodgkin's lymphoma undergoing disease staging at diagnosis and initial treatment response assessment. At each time point...
Eligibility Criteria
Inclusion
- Aged 5 to 20 years (inclusive) with participant and parent/guardian informed consent
- Histologically confirmed first presentation of Hodgkin's Lymphoma
- Either entered into the Euronet PHL-C1 trial or LP1 trials OR not formally entered into the Euronet trials but treated on the chemotherapy regimens of the Euronet trials for classical and lymphocyte predominant Hodgkin Lymphoma
Exclusion
- Contraindications to MRI (e.g. pacemaker)
- Previous malignancy or previous chemotherapy or radiotherapy treatment for malignancy
- Pregnancy or nursing
Key Trial Info
Start Date :
September 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2015
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT01459224
Start Date
September 1 2011
End Date
October 1 2015
Last Update
December 3 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University College London Hospital (UCLH)
London, United Kingdom